MS News Alert: UAE first to approve tolebrutinib for treating adults with nonrelapsing SPMS. "MultipleSclerosisNewsToday.com" is noted as source at bottom.

The oral BTK inhibitor is the first approved therapy to directly address the chronic inflammation that contributes to disability progression independent of relapses. See how it works: https://bit.ly/4lSD9Dw

#MS #MultipleSclerosis #MSNews #MSTreatment #MSCommunity #TherapyApproval #Bionews